PyroGenesis Canada (PYRGF) Competitors $0.49 0.00 (0.00%) (As of 11/20/2024 ET) Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesSEC FilingsTrends PYRGF vs. AMLX, ALEC, CTNM, KMDA, QTTB, BTMD, ACIU, JSPR, ACRS, and DSGNShould you be buying PyroGenesis Canada stock or one of its competitors? The main competitors of PyroGenesis Canada include Amylyx Pharmaceuticals (AMLX), Alector (ALEC), Contineum Therapeutics (CTNM), Kamada (KMDA), Q32 Bio (QTTB), biote (BTMD), AC Immune (ACIU), Jasper Therapeutics (JSPR), Aclaris Therapeutics (ACRS), and Design Therapeutics (DSGN). These companies are all part of the "pharmaceutical products" industry. PyroGenesis Canada vs. Amylyx Pharmaceuticals Alector Contineum Therapeutics Kamada Q32 Bio biote AC Immune Jasper Therapeutics Aclaris Therapeutics Design Therapeutics PyroGenesis Canada (NASDAQ:PYRGF) and Amylyx Pharmaceuticals (NASDAQ:AMLX) are both small-cap industrial products companies, but which is the superior business? We will contrast the two businesses based on the strength of their valuation, media sentiment, profitability, analyst recommendations, institutional ownership, earnings, dividends, risk and community ranking. Which has higher valuation & earnings, PYRGF or AMLX? Amylyx Pharmaceuticals has higher revenue and earnings than PyroGenesis Canada. PyroGenesis Canada is trading at a lower price-to-earnings ratio than Amylyx Pharmaceuticals, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioPyroGenesis Canada$9.14M9.78-$21.12M-$0.06-8.09Amylyx Pharmaceuticals$380.79M0.93$49.27M-$3.82-1.35 Does the media prefer PYRGF or AMLX? In the previous week, Amylyx Pharmaceuticals had 8 more articles in the media than PyroGenesis Canada. MarketBeat recorded 10 mentions for Amylyx Pharmaceuticals and 2 mentions for PyroGenesis Canada. Amylyx Pharmaceuticals' average media sentiment score of 0.90 beat PyroGenesis Canada's score of 0.00 indicating that Amylyx Pharmaceuticals is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment PyroGenesis Canada 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Amylyx Pharmaceuticals 2 Very Positive mention(s) 3 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has more volatility & risk, PYRGF or AMLX? PyroGenesis Canada has a beta of 0.84, meaning that its stock price is 16% less volatile than the S&P 500. Comparatively, Amylyx Pharmaceuticals has a beta of -0.7, meaning that its stock price is 170% less volatile than the S&P 500. Does the MarketBeat Community prefer PYRGF or AMLX? Amylyx Pharmaceuticals received 32 more outperform votes than PyroGenesis Canada when rated by MarketBeat users. CompanyUnderperformOutperformPyroGenesis CanadaN/AN/AAmylyx PharmaceuticalsOutperform Votes3265.31% Underperform Votes1734.69% Do analysts recommend PYRGF or AMLX? Amylyx Pharmaceuticals has a consensus target price of $11.43, suggesting a potential upside of 121.48%. Given Amylyx Pharmaceuticals' stronger consensus rating and higher probable upside, analysts clearly believe Amylyx Pharmaceuticals is more favorable than PyroGenesis Canada.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score PyroGenesis Canada 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Amylyx Pharmaceuticals 0 Sell rating(s) 5 Hold rating(s) 4 Buy rating(s) 1 Strong Buy rating(s) 2.60 Do institutionals and insiders believe in PYRGF or AMLX? 0.0% of PyroGenesis Canada shares are held by institutional investors. Comparatively, 95.8% of Amylyx Pharmaceuticals shares are held by institutional investors. 47.7% of PyroGenesis Canada shares are held by company insiders. Comparatively, 11.7% of Amylyx Pharmaceuticals shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth. Is PYRGF or AMLX more profitable? Amylyx Pharmaceuticals has a net margin of -17.86% compared to PyroGenesis Canada's net margin of -115.14%. Amylyx Pharmaceuticals' return on equity of -36.97% beat PyroGenesis Canada's return on equity.Company Net Margins Return on Equity Return on Assets PyroGenesis Canada-115.14% -1,365.53% -59.31% Amylyx Pharmaceuticals -17.86%-36.97%-29.61% SummaryAmylyx Pharmaceuticals beats PyroGenesis Canada on 14 of the 18 factors compared between the two stocks. Ad Angel PublishingTesla Execs are Freaking OutIt’s so revolutionary that tech giants like Microsoft, Amazon, and NVIDIA are all lining up to get their hands on it. And Elon Musk has completely restructured Tesla to chase this opportunity. This is a once-in-a-lifetime opportunity that you don’t want to miss.Click here to get the details. Get PyroGenesis Canada News Delivered to You Automatically Sign up to receive the latest news and ratings for PYRGF and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart PYRGF vs. The Competition Export to ExcelMetricPyroGenesis CanadaPharmaceutical IndustryIndustrial SectorNASDAQ ExchangeMarket Cap$89.35M$6.48B$9.57B$8.80BDividend YieldN/A8.11%2.03%4.07%P/E Ratio-8.094.9718.8213.60Price / Sales9.78371.457.9987.40Price / CashN/A52.5920.3036.27Price / Book-48.5510.303.976.33Net Income-$21.12M$153.61M$413.78M$225.93M7 Day Performance-7.26%-1.73%-1.72%-0.96%1 Month Performance-22.36%-7.26%1.14%1.06%1 Year Performance25.39%31.10%29.33%26.59% PyroGenesis Canada Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)PYRGFPyroGenesis CanadaN/A$0.49flatN/A+27.8%$89.35M$9.14M-8.0990News CoverageGap UpAMLXAmylyx Pharmaceuticals4.3626 of 5 stars$5.16-1.3%$11.43+121.5%-59.5%$353.72M$380.79M0.00200Analyst UpgradeALECAlector4.3736 of 5 stars$3.57-1.7%$20.67+478.9%-26.1%$349.61M$97.06M-2.14270Positive NewsCTNMContineum Therapeutics1.6433 of 5 stars$13.50-1.1%$29.25+116.7%N/A$348.03M$50M0.0031KMDAKamada3.8063 of 5 stars$5.85+0.5%$14.50+147.9%+23.3%$336.26M$142.52M20.79360Analyst RevisionQTTBQ32 Bio1.6142 of 5 stars$27.24-0.1%$72.33+165.5%N/A$331.78M$1.16M0.0039BTMDbiote3.1975 of 5 stars$5.95-1.8%$8.39+41.0%+19.8%$322.61M$185.36M23.31194ACIUAC Immune2.2991 of 5 stars$3.24flat$12.00+270.4%+0.0%$320.57M$16.48M0.00140Positive NewsJSPRJasper Therapeutics2.6633 of 5 stars$21.10+0.6%$74.86+254.8%+227.3%$316.50MN/A0.0020ACRSAclaris Therapeutics3.948 of 5 stars$4.42+11.6%$8.80+99.1%+321.2%$315.72M$31.25M-8.7186Analyst UpgradeInsider TradeAnalyst RevisionNews CoverageGap UpDSGNDesign Therapeutics1.7541 of 5 stars$5.57+1.6%$7.00+25.7%+145.7%$315.37MN/A0.0040 Related Companies and Tools Related Companies AMLX Alternatives ALEC Alternatives CTNM Alternatives KMDA Alternatives QTTB Alternatives BTMD Alternatives ACIU Alternatives JSPR Alternatives ACRS Alternatives DSGN Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:PYRGF) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding PyroGenesis Canada Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share PyroGenesis Canada With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free PYRGF Stock Alerts